ACRV

ACRV · Acrivon Therapeutics Inc. Common Stock

View on chart

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 15, 2026

Acrivon Therapeutics noted among health‑care stocks moving in after‑market. Acrivon Therapeutics (ACRV) was included in a Benzinga roundup of twelve health‑care stocks that showed price movement during Wednesday’s after‑market session. The mention signals recent trading activity after regular hours. The stock is currently near its 52‑week low and its RSI is below 40, suggesting limited momentum.

this person other insiders at ACRV

Insiders & Stakes

Chione Ltd
10% Owner
3,848,632
Shares held
PERCEPTIVE ADVISORS LLC
Director
3,104,139
Shares held
Peter Blume-Jensen
President and CEO
2,230,052
Shares held
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
888,130
Shares held
Masson Kristina
EVP - Business Operations
317,246
Shares held
Eric Devroe
Chief Operating Officer
146,349
Shares held
Mary Miller
Chief Legal Officer
81,715
Shares held
Adam D. Levy
Chief Financial Officer
66,008
Shares held
Erick Gamelin
Chief Medical Officer
52,592
Shares held
Mansoor Raza Mirza
Director
38,817
Shares held
Levin Michaela
Chief Business Officer
30,000
Shares held
Holm-Jorgensen Rasmus
Chief Financial Officer
26,088
Shares held
Katharine Peterson
Chief Accounting Officer
18,033
Shares held
RA CAPITAL MANAGEMENT, L.P.
Director
9,366
Shares held
Ivana Magovcevic-Liebisch9,366
Shares held
Michael John Tomsicek
Director
9,366
Shares held
Sharon Shacham
Chief Scientific Officer
9,366
Shares held
Santhosh Palani9,366
Shares held
Derek DiRocco
Director
9,366
Shares held
Charles M. Baum9,366
Shares held

Transaction History

Mary Miller▼ Sell$585
Levin Michaela▲ Buy$0
Peter Blume-Jensen▼ Sell$31K
Katharine Peterson▼ Sell$203
Mary Miller▼ Sell$372
Erick Gamelin▼ Sell$804
Eric Devroe▼ Sell$1K
Peter Blume-Jensen▼ Sell$2K
Peter Blume-Jensen▼ Sell$973
Adam D. Levy▼ Sell$2K
Mary Miller▼ Sell$1K
Peter Blume-Jensen▼ Sell$25K
Michael John Tomsicek▲ Buy$0
RA CAPITAL MANAGEMENT, L.P.▲ Buy$0
Sharon Shacham▲ Buy$0
Santhosh Palani▲ Buy$0
Ivana Magovcevic-Liebisch▲ Buy$0
Charles M. Baum▲ Buy$0
Katharine Peterson▲ Buy$0
Mansoor Raza Mirza▲ Buy$0
Mary Miller▲ Buy$0
Adam D. Levy▲ Buy$0
Erick Gamelin▲ Buy$0
Eric Devroe▲ Buy$0
Peter Blume-Jensen▲ Buy$0
Derek DiRocco▲ Buy$0
Peter Blume-Jensen▲ Buy$0
Katharine Peterson▼ Sell$190
Mary Miller▼ Sell$353
Erick Gamelin▼ Sell$776
Eric Devroe▼ Sell$1K
Peter Blume-Jensen▼ Sell$2K
Peter Blume-Jensen▼ Sell$941
RA CAPITAL MANAGEMENT, L.P.▲ Buy$7.0M
Mary Miller▼ Sell$993
Peter Blume-Jensen▼ Sell$22K
Katharine Peterson▼ Sell$189
Mary Miller▼ Sell$354
Erick Gamelin▼ Sell$768
Eric Devroe▼ Sell$1K
Peter Blume-Jensen▼ Sell$2K
Peter Blume-Jensen▼ Sell$944
Mary Miller▼ Sell$1K
Peter Blume-Jensen▲ Buy$82K
Adam D. Levy▲ Buy$15K
Eric Devroe▲ Buy$17K
Peter Blume-Jensen▼ Sell$46K
Katharine Peterson▼ Sell$222
Mary Miller▼ Sell$412
Erick Gamelin▼ Sell$903
Eric Devroe▼ Sell$1K
Peter Blume-Jensen▼ Sell$134K
Peter Blume-Jensen▼ Sell$1K
Mary Miller▼ Sell$1K
Mary Miller▼ Sell$514
Peter Blume-Jensen▼ Sell$26K
Erick Gamelin▼ Sell$560
Mary Miller▼ Sell$256
Katharine Peterson▼ Sell$138
Eric Devroe▼ Sell$852
Peter Blume-Jensen▼ Sell$83K
Peter Blume-Jensen▼ Sell$681
Adam D. Levy▼ Sell$1K
Mary Miller▼ Sell$737
Peter Blume-Jensen▼ Sell$23K
Erick Gamelin▼ Sell$459
Eric Devroe▼ Sell$699
Katharine Peterson▼ Sell$113
Mary Miller▼ Sell$210
Peter Blume-Jensen▼ Sell$68K
Peter Blume-Jensen▼ Sell$560
PERCEPTIVE ADVISORS LLC▼ Sell$401K
PERCEPTIVE ADVISORS LLC▼ Sell$617K
PERCEPTIVE ADVISORS LLC▼ Sell$353K
PERCEPTIVE ADVISORS LLC▼ Sell$336K
PERCEPTIVE ADVISORS LLC▼ Sell$2.1M
Mary Miller▼ Sell$1K
Peter Blume-Jensen▼ Sell$110K
Katharine Peterson▼ Sell$629
Mary Miller▼ Sell$1K
Holm-Jorgensen Rasmus▼ Sell$2K
Erick Gamelin▼ Sell$3K
Eric Devroe▼ Sell$4K
Peter Blume-Jensen▼ Sell$201K
Peter Blume-Jensen▼ Sell$3K
Mary Miller▼ Sell$4K
Peter Blume-Jensen▼ Sell$128K
Mary Miller▼ Sell$1K
Holm-Jorgensen Rasmus▼ Sell$3K
Erick Gamelin▼ Sell$3K
Eric Devroe▼ Sell$5K
Katharine Peterson▼ Sell$784
Peter Blume-Jensen▼ Sell$473K
Peter Blume-Jensen▼ Sell$4K
Mary Miller▼ Sell$4K
Mary Miller▼ Sell$2K
Peter Blume-Jensen▼ Sell$732K
Eric Devroe▼ Sell$4K
Peter Blume-Jensen▼ Sell$420K
Katharine Peterson▼ Sell$695
Mary Miller▼ Sell$1K
Masson Kristina▼ Sell$3K
Holm-Jorgensen Rasmus▼ Sell$3K
Erick Gamelin▼ Sell$3K
Mary Miller▼ Sell$4K
Eric Devroe▲ Buy$10K
Katharine Peterson▼ Sell$828
Mary Miller▼ Sell$2K
Masson Kristina▼ Sell$4K
Holm-Jorgensen Rasmus▼ Sell$3K
Erick Gamelin▼ Sell$3K
Eric Devroe▼ Sell$5K
Peter Blume-Jensen▼ Sell$459K
Mary Miller▼ Sell$6K
RA CAPITAL MANAGEMENT, L.P.▲ Buy$30.0M
PERCEPTIVE ADVISORS LLC▲ Buy$20.0M
Mary Miller▼ Sell$738
Masson Kristina▼ Sell$2K
Holm-Jorgensen Rasmus▼ Sell$1K
Erick Gamelin▼ Sell$2K
Eric Devroe▼ Sell$2K
Peter Blume-Jensen▼ Sell$142K
Mary Miller▼ Sell$3K
Eric Devroe▼ Sell$12K
Peter Blume-Jensen▼ Sell$1.2M
Mary Miller▼ Sell$4K
Masson Kristina▼ Sell$10K
Holm-Jorgensen Rasmus▼ Sell$7K
Erick Gamelin▼ Sell$7K
Mary Miller▼ Sell$12K
Mary Miller▲ Buy$0
Peter Blume-Jensen▲ Buy$0
Chione Ltd▼ Sell$207
Holm-Jorgensen Rasmus▲ Buy$34K
Chione Ltd▼ Sell$25K
Chione Ltd▼ Sell$11K
Chione Ltd▼ Sell$37K
Chione Ltd▼ Sell$25K
Eric Devroe▲ Buy$10K
Peter Blume-Jensen▲ Buy$130K
Chione Ltd▲ Buy$5.0M
RA CAPITAL MANAGEMENT, L.P.▲ Buy$42.4M
RA CAPITAL MANAGEMENT, L.P.▼ Sell—
RA CAPITAL MANAGEMENT, L.P.▼ Sell—
Chione Ltd▼ Sell—
Chione Ltd▼ Sell—
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.▼ Sell—
Erick Gamelin▲ Buy$0
Eric Devroe▲ Buy$0
Holm-Jorgensen Rasmus▲ Buy$0
Masson Kristina▲ Buy$0
Masson Kristina▲ Buy$0
Masson Kristina▲ Buy$0
Masson Kristina▲ Buy$0
Peter Blume-Jensen▲ Buy$0
Peter Blume-Jensen▲ Buy$0
Peter Blume-Jensen▲ Buy$0
Peter Blume-Jensen▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.